Levodopa-induced dyskinesias in mitochondrial membrane protein-associated neurodegeneration.
作者信息
Savitt Daniel, Jankovic Joseph
机构信息
Department of Neurology, Parkinson's Disease and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX.
出版信息
Neurol Clin Pract. 2019 Feb;9(1):e7-e9. doi: 10.1212/CPJ.0000000000000577.
Abstract
摘要
相似文献
1
Levodopa-induced dyskinesias in mitochondrial membrane protein-associated neurodegeneration.线粒体膜蛋白相关神经退行性变中的左旋多巴诱发的异动症
Neurol Clin Pract. 2019 Feb;9(1):e7-e9. doi: 10.1212/CPJ.0000000000000577.
2
Investigating levodopa-induced dyskinesias in the parkinsonian primate.研究帕金森病灵长类动物中左旋多巴诱发的异动症。
Ann Neurol. 2000 Apr;47(4 Suppl 1):S79-89.
3
Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa.诺米芬辛和左旋多巴诱发正常松鼠猴出现运动障碍。
Neuropharmacology. 2005 Mar;48(3):398-405. doi: 10.1016/j.neuropharm.2004.10.009. Epub 2005 Jan 28.
4
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.尼古丁可减轻损毁猴模型中左旋多巴诱导的异动症。
Ann Neurol. 2007 Dec;62(6):588-96. doi: 10.1002/ana.21203.
5
Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.帕金森病和左旋多巴诱导运动障碍中的血清素标志物。
Mov Disord. 2015 May;30(6):796-804. doi: 10.1002/mds.26144. Epub 2015 Feb 4.
6
A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.以额下回为中心的神经网络与左旋多巴诱导的异动症密切相关。
Brain. 2015 Feb;138(Pt 2):414-27. doi: 10.1093/brain/awu329. Epub 2014 Nov 19.
7
Medical treatment of levodopa-induced dyskinesias.左旋多巴诱导的运动障碍的医学治疗。
Ann Neurol. 2000 Apr;47(4 Suppl 1):S179-88.
8
Bilateral low frequency rTMS of the primary motor cortex may not be a suitable treatment for levodopa-induced dyskinesias in late stage Parkinson's disease.对原发性运动皮层进行双侧低频重复经颅磁刺激可能不是治疗晚期帕金森病左旋多巴诱导的异动症的合适方法。
Parkinsonism Relat Disord. 2016 Jan;22:54-61. doi: 10.1016/j.parkreldis.2015.11.009.
9
Axial levodopa-induced dyskinesias and neuronal activity in the dorsal striatum.轴向左旋多巴诱发的异动症与背侧纹状体中的神经元活动
Neuroscience. 2017 Feb 20;343:240-249. doi: 10.1016/j.neuroscience.2016.11.046. Epub 2016 Dec 9.
10
Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias.先前有左旋多巴诱导的运动障碍随后接受胎儿多巴胺前体移植的帕金森病猴未出现移植诱导的运动障碍。
J Comp Neurol. 2017 Feb 15;525(3):498-512. doi: 10.1002/cne.24081. Epub 2016 Aug 29.
引用本文的文献
1
Cerebral Iron Deposition in Neurodegeneration.脑铁沉积与神经变性疾病。
Biomolecules. 2022 May 17;12(5):714. doi: 10.3390/biom12050714.
本文引用的文献
1
Mitochondrial membrane protein-associated neurodegeneration: a case report and literature review.线粒体膜蛋白相关神经退行性变：一例报告及文献综述
Neurocase. 2018 Jun;24(3):161-165. doi: 10.1080/13554794.2018.1506038. Epub 2018 Aug 8.
2
Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.福司美坦戊酸酯（RE-024），一种泛酸激酶相关神经退行性变的磷酸泛酰巯基乙胺替代疗法：作用机制和非临床模型中的疗效。
PLoS One. 2018 Mar 9;13(3):e0192028. doi: 10.1371/journal.pone.0192028. eCollection 2018.
3
Neurodegeneration with brain iron accumulation.伴有脑铁沉积的神经退行性变
Handb Clin Neurol. 2017;145:157-166. doi: 10.1016/B978-0-12-802395-2.00011-0.
4
C19orf12 gene mutations in patients with neurodegeneration with brain iron accumulation.脑铁沉积神经退行性变患者的C19orf12基因突变
Parkinsonism Relat Disord. 2015 Jul;21(7):813-6. doi: 10.1016/j.parkreldis.2015.04.009. Epub 2015 Apr 23.
5
Neurodegeneration with brain iron accumulation: diagnosis and management.脑铁蓄积性神经退行性变：诊断与管理。
J Mov Disord. 2015 Jan;8(1):1-13. doi: 10.14802/jmd.14034. Epub 2015 Jan 13.
6
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN.新的 NBIA 亚型：MPAN 的遗传、临床、病理和放射特征。
Neurology. 2013 Jan 15;80(3):268-75. doi: 10.1212/WNL.0b013e31827e07be. Epub 2012 Dec 26.
7
Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.缺失孤儿线粒体蛋白 c19orf12 导致具有脑铁蓄积的神经退行性变的独特临床亚型。
Am J Hum Genet. 2011 Oct 7;89(4):543-50. doi: 10.1016/j.ajhg.2011.09.007.
Zotero 插件